0000914190-21-000394.txt : 20211101
0000914190-21-000394.hdr.sgml : 20211101
20211101163639
ACCESSION NUMBER: 0000914190-21-000394
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211028
FILED AS OF DATE: 20211101
DATE AS OF CHANGE: 20211101
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hippel James
CENTRAL INDEX KEY: 0001603594
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-17272
FILM NUMBER: 211367757
MAIL ADDRESS:
STREET 1: 614 MCKINLEY PLACE NE
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIO-TECHNE Corp
CENTRAL INDEX KEY: 0000842023
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 411427402
STATE OF INCORPORATION: MN
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 614 MCKINLEY PL N E
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
BUSINESS PHONE: 6123798854
MAIL ADDRESS:
STREET 1: 614 MCKINLEY PLACE NE
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
FORMER COMPANY:
FORMER CONFORMED NAME: TECHNE CORP /MN/
DATE OF NAME CHANGE: 19920703
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2021-10-28
0000842023
BIO-TECHNE Corp
TECH
0001603594
Hippel James
614 MCKINLEY PLACE N.E.
MINNEAPOLIS
MN
55413
0
1
0
0
Chief Financial Officer
Common Stock
2021-10-28
4
S
0
100
525.18
D
10755
D
Common Stock
2021-10-29
4
M
0
662
125.05
A
11417
D
Common Stock
2021-10-29
4
S
0
662
525.2327
D
10755
D
Stock Options (Right to Buy)
125.05
2021-10-29
4
M
0
662
0
D
2024-08-09
Common Stock
662
56411
D
Stock Options (Right to Buy)
177.32
2025-08-08
Common Stock
18066
18066
D
Stock Options (Right to Buy)
177.32
2025-08-08
Common Stock
24089
24089
D
Restricted Stock Units
Common Stock
3938
3938
D
Stock Options (Right to Buy)
190.41
2026-08-07
Common Stock
19936
19936
D
Stock Options (Right to Buy)
190.41
2026-08-07
Common Stock
26581
26581
D
Restricted Stock Units
Common Stock
3219
3219
D
Stock Options (Right to Buy)
267.87
2027-08-05
Common Stock
14360
14360
D
Stock Options (Right to Buy)
267.87
2027-08-05
Common Stock
19147
19147
D
Stock Options (Right to Buy)
267.87
2027-08-05
Common Stock
8325
8325
D
Stock Options (Right to Buy)
267.87
2027-08-05
Common Stock
8325.0
8325.0
D
Restricted Stock Units
Common Stock
1945
1945
D
Stock Options (Right to Buy)
481.82
2028-08-06
Common Stock
7600
7600
D
Stock Options (Right to Buy)
481.82
2028-08-06
Common Stock
10134
10134
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $525.10 to $525.59, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock.
Fully exercisable.
Options to purchase 6,023 shares vest on 8/8/2019 and options to purchase 6,022 shares vest on each of 8/8/2020, 8/8/2021 and 8/8/2022.
Vests in full or in part on 8/7/2022 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Options to purchase 6,646 shares vest on 8/7/2020 and options to purchase 6,645 shares vest on each of 8/7/2021, 8/7/2022 and 8/7/2023.
Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Options to purchase 4,787 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023 and options to purchase 4,786 shares vest on 8/5/2024.
Options to purchase 2,775 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023.
Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021.
Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Options to purchase 2,534 shares vest on each of 8/6/2022 and 8/6/2023 and options to purchase 2,533 shares vest on each of 8/6/2024 and 8/6/2025.
/s/ Brenda S. Furlow, Attorney-in-Fact for James Hippel pursuant to Power of Attorney previously filed.
2021-11-01